IGF-1 gene therapy can reduce the reactivity of astrocytes in response to proinflammatory stimuli in vitro [26] and exert neuroprotective and neuroreparative actions in experimental animal models of hypoxia and stroke [27–29]. Here, IGF1 is linked to Stroke.